$51.29
2.90% yesterday
NYSE, Oct 03, 10:00 pm CET
ISIN
US4333131039
Symbol
HNGE

Hinge Health Stock price

$51.29
-6.15 10.71% 1M
+19.29 60.28% 6M
+19.29 60.28% YTD
+19.29 60.28% 1Y
+19.29 60.28% 3Y
+19.29 60.28% 5Y
+19.29 60.28% 10Y
+19.29 60.28% 20Y
NYSE, Closing price Fri, Oct 03 2025
-1.53 2.90%
ISIN
US4333131039
Symbol
HNGE

Key metrics

Basic
Market capitalization
$4.0b
Enterprise Value
$3.6b
Net debt
positive
Cash
$413.3m
Shares outstanding
78.1m
Valuation (TTM | estimate)
P/E
negative | 86.2
P/S
6.2 | 7.2
EV/Sales
5.5 | 6.4
EV/FCF
35.6
P/B
10.8
Financial Health
Equity Ratio
61.9%
Return on Equity
-2.9%
ROCE
-157.9%
ROIC
1,875.4%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$653.3m | $561.5m
EBITDA
$-592.5m | $82.1m
EBIT
$-599.4m | $78.7m
Net Income
$-674.6m | $46.5m
Free Cash Flow
$101.4m
Growth (TTM | estimate)
Revenue
- | 43.8%
EBITDA
- | 544.5%
EBIT
- | 422.1%
Net Income
- | 489.7%
Free Cash Flow
-
Margin (TTM | estimate)
Gross
76.2%
EBITDA
-90.7% | 14.6%
EBIT
-91.8%
Net
-103.3% | 8.3%
Free Cash Flow
15.5%
More
EPS
$-15.4
FCF per Share
$1.3
Short interest
4.3%
Employees
-
Rev per Employee
-
Show more

Is Hinge Health a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,001 stocks worldwide.

Hinge Health Stock Analysis

Unlock Scores for Free

Analyst Opinions

21 Analysts have issued a Hinge Health forecast:

19x Buy
90%
2x Hold
10%

Analyst Opinions

21 Analysts have issued a Hinge Health forecast:

Buy
90%
Hold
10%

Financial data from Hinge Health

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
653 653
-
100%
- Direct Costs 155 155
-
24%
498 498
-
76%
- Selling and Administrative Expenses 693 693
-
106%
- Research and Development Expense 404 404
-
62%
-592 -592
-
-91%
- Depreciation and Amortization 6.98 6.98
-
1%
EBIT (Operating Income) EBIT -599 -599
-
-92%
Net Profit -675 -675
-
-103%

In millions USD.

Don't miss a Thing! We will send you all news about Hinge Health directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Hinge Health Stock News

Neutral
Business Wire
3 days ago
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) announced today that it will report its financial results for the quarter ended September 30, 2025, after the U.S. markets close on Tuesday, November 4, 2025. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio we...
Positive
CNBC
about 2 months ago
Shares of Hinge Health popped after the digital physical therapy company reported quarterly results that beat analysts' estimates for revenue. The company reported quarterly results for the first time since its debut on the New York Stock Exchange in May.
Positive
Investors Business Daily
about 2 months ago
Hinge Health, which went public in May, reported light second-quarter sales. But the IPO stock popped in late trades Tuesday.
More Hinge Health News

Company Profile

Hinge Health Inc is a US-based company operating in Health Care Providers & Services industry. The company is headquartered in San Francisco, California. The company went IPO on 2025-05-22. Hinge Health, Inc. leverages software, including artificial intelligence (AI), to largely automate care for joint and muscle health. The firm has designed its TrueMotion platform to address a spectrum of musculoskeletal (MSK) care from acute injury to chronic pain, to post-surgical rehabilitation. Members receive personalized and automated MSK care through its AI-powered motion tracking technology. The company offers electrical nerve stimulation wearable device Enso, all designed and monitored by its AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Its platform offers a range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. Enso delivers electrical nerve stimulation designed to provide non-addictive and non-invasive pain relief.

Head office United States
Website en-gb.hingehealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today